Placebo in Cancer Trials: What Is Actually True

Part of Understanding Cancer Trials: Randomization and placebo.

About 4 minutes. Free, in your language, no account needed.

This is general education about clinical research — not medical advice, and not a way to join a study. Talk to your own doctor about your situation.

This is one of the most common worries people have about cancer trials, and one of the most common misunderstandings. It deserves a direct answer.

The worry usually sounds like this: if I join a study, I might get a sugar pill instead of cancer treatment.

What a placebo is

A placebo is something made to look, taste and feel like the treatment being tested, but with no active medicine in it. It might be a tablet, or an infusion of salt water.

It exists so that everyone in the study goes through the same experience, and so that differences found at the end can be attributed to the active ingredient rather than to the routine, the attention, or the expectation.

The two things that are actually true

First: placebos are uncommon in cancer treatment studies. The US National Cancer Institute states plainly that placebos are rarely used in cancer treatment clinical trials. Most studies compare a new treatment against the treatment that is already standard, not against nothing.

Second: when a placebo is used, it is usually added on top of treatment, not used instead of it. The typical design compares standard treatment plus a placebo against standard treatment plus the study treatment. Everyone in that study receives the standard treatment. The placebo is there so that the two groups differ only in the one thing being tested.

Being in the placebo arm of such a study does not mean being untreated. It means receiving the current standard treatment, plus something that is not active.

When a placebo might be used on its own

There are situations where a placebo is compared against no active treatment. The main one is where there is no standard treatment for that situation, so there is nothing to withhold.

This is also written into international research ethics. The World Medical Association's Declaration of Helsinki, in its October 2024 version, states at paragraph 33 that a new intervention must be tested against the best proven intervention, and allows a placebo or no intervention only where no proven intervention exists, or where there are compelling and scientifically sound methodological reasons and participants will not be exposed to additional risks of serious or irreversible harm. The same paragraph adds that extreme care must be taken to avoid abuse of this option.

That is a narrow door, and it is meant to be.

What you are entitled to know

You should never find out about a placebo by accident.

If a study uses a placebo, the consent process must tell you before you decide. You are entitled to ask, and to be given a clear answer to, all of the following:

• Does this study use a placebo at all?
• If it does, is it added to standard treatment, or given instead of a treatment?
• What is the chance of being in each arm?
• What treatment would I receive in each arm?
• What would happen if my disease got worse while I was in the study?

If the answers to those questions are not clear to you, that is a reason to keep asking, not a reason to assume.

In short

• A placebo looks like the treatment but contains no active medicine.
• Placebos are rarely used in cancer treatment studies.
• When they are used, the usual design adds a placebo on top of standard treatment, so nobody goes without standard treatment.
• Placebo alone is limited to narrow situations, mainly where no proven treatment exists, and international ethics guidance restricts it deliberately.
• If a study uses a placebo, you must be told before you decide, and you can ask exactly how it is used.